XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Abingworth
Common Stock
Common Stock
Abingworth
Additional Paid-in-Capital
Additional Paid-in-Capital
Abingworth
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2020     353,500,000            
Beginning balance at Dec. 31, 2020 $ 2,930.2   $ 3.5   $ 2,546.2   $ 348.2 $ (208.7) $ 241.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares) (1,900,000)   (1,900,000)            
Shares repurchased $ (84.5)           (84.5)    
Equity-based compensation 125.6   $ 0.1   125.5        
Shares issued for equity-based awards (in shares)     4,900,000            
Contributions 57.2               57.2
Distributions (343.0)           (266.7)   (76.3)
Net income 2,384.8           2,327.1   57.7
Currency translation adjustments (41.2)             (35.4) (5.8)
Defined benefit plans, net 3.9             3.9  
Ending balance (in shares) at Sep. 30, 2021     356,500,000            
Ending balance at Sep. 30, 2021 5,033.0   $ 3.6   2,671.7   2,324.1 (240.2) 273.8
Beginning balance (in shares) at Jun. 30, 2021     354,500,000            
Beginning balance at Jun. 30, 2021 4,622.0   $ 3.5   2,621.7   1,940.1 (228.3) 285.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares)     (1,300,000)            
Shares repurchased (59.5)           (59.5)    
Equity-based compensation 50.1   $ 0.1   50.0        
Shares issued for equity-based awards (in shares)     3,300,000            
Contributions 12.8               12.8
Distributions (122.7)           (89.3)   (33.4)
Net income 547.4           532.8   14.6
Currency translation adjustments (18.0)             (12.8) (5.2)
Defined benefit plans, net 0.9             0.9  
Ending balance (in shares) at Sep. 30, 2021     356,500,000            
Ending balance at Sep. 30, 2021 $ 5,033.0   $ 3.6   2,671.7   2,324.1 (240.2) 273.8
Beginning balance (in shares) at Dec. 31, 2021 355,367,876   355,400,000            
Beginning balance at Dec. 31, 2021 $ 5,706.2   $ 3.6   2,717.6   2,805.3 (247.5) 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares) (3,600,000)   (3,600,000)            
Shares repurchased $ (146.9)           (146.9)    
Equity-based compensation 147.0       147.0        
Shares issued for equity-based awards (in shares)     5,900,000            
Shares issued for performance allocations (in shares)     900,000            
Shares issued for performance allocations 38.9       38.9        
Shares issued related to the acquisition of CBAM (in shares)     4,200,000 600,000          
Shares issued related to the acquisition of CBAM 194.5 $ 25.0     194.5 $ 25.0      
Contributions 282.1               282.1
Distributions (498.9)           (325.4)   (173.5)
Non-controlling interests related to the acquisition of Abingworth 4.2               4.2
Net income 1,126.1           1,097.8   28.3
Currency translation adjustments (219.3)             (188.2) (31.1)
Defined benefit plans, net $ (4.0)             (4.0)  
Ending balance (in shares) at Sep. 30, 2022 363,372,564   363,400,000            
Ending balance at Sep. 30, 2022 $ 6,654.9   $ 3.6   3,123.0   3,430.8 (439.7) 537.2
Beginning balance (in shares) at Jun. 30, 2022     361,200,000            
Beginning balance at Jun. 30, 2022 6,432.3   $ 3.6   3,033.6   3,309.9 (360.8) 446.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares)     (1,200,000)            
Shares repurchased (41.6)           (41.6)    
Equity-based compensation 62.0       62.0        
Shares issued for equity-based awards (in shares)     2,600,000            
Shares issued for performance allocations (in shares)     200,000            
Shares issued for performance allocations 2.4       2.4        
Shares issued related to the acquisition of CBAM (in shares)       600,000          
Shares issued related to the acquisition of CBAM   $ 25.0       $ 25.0      
Contributions 115.2               115.2
Distributions (135.2)           (118.3)   (16.9)
Non-controlling interests related to the acquisition of Abingworth 4.2               4.2
Net income 282.4           280.8   1.6
Currency translation adjustments (91.8)             (78.9) (12.9)
Defined benefit plans, net $ 0.0             0.0  
Ending balance (in shares) at Sep. 30, 2022 363,372,564   363,400,000            
Ending balance at Sep. 30, 2022 $ 6,654.9   $ 3.6   $ 3,123.0   $ 3,430.8 $ (439.7) $ 537.2